NPR-B natriuretic peptide receptors in human corneal epithelium: mRNA, immunohistochemistochemical, protein, and biochemical pharmacology studies

Molecular Vision

Volumn 16, Issue , 2010, Pages 1141-1152

  Katoli, Parvaneh ^a   Sharif, Najam A ^a   Sule, Anupam ^b   Dimitrijevich, Slobodan D ^b  

^a ALCON RESEARCH LTD   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; HS 142 1; ISATIN; MESSENGER RNA; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C;

ADULT; AGED; ARTICLE; CELL IMMORTALIZATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; ENZYME IMMUNOASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 77955635425     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985; 230:767-70.
2. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332:78-81.
3. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168:863-70.
4. Drewett JG, Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocr Rev 1994; 15:135-62.
5. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: their structures, receptors, physiological functions and therapeutic applications. Handbook Exp Pharmacol. 2009; 191:341-66.
6. Silberbach M, Roberts CT. Natriuretic peptide signaling: molecular and cellular pathways to growth regulation. Cell Signal 2001; 13:221-31.
7. Gutkowska J, Nemer M. Structure, expression, and function of atrial natriuretic factor in extra-atrial tissues. Endocr Rev 1989; 10:519-36.
8. Koller KJ, Lowe DG, Bennett GL, Koller KJ, Lowe DG, Bennett GL, Minamino N, Kanawa K, Matsuo H, Goeddel DV. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991; 252:120-3.
9. Pilz RB, Casteel DE. Regulation of gene expression by cyclic GMP. Circ Res 2003; 93:1034-46.
10. Waldman SA, Lucas KA, Pitari GM, Kazaerounion S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52:375-414.
11. Beavo JA, Brunton LL. Cyclic nucleotide research: still expanding after half a century. Nat Rev Mol Cell Biol 2002; 3:710-8.
12. Stone RA, Glembotski CC. Immunoactive natriuretic peptide in the rat eye: molecular forms in anterior uvea and retina. Biochem Biophys Res Commun 1986; 134:1022-8.
13. Yamamoto R, McGlinn A, Stone RA. Brain natriuretic peptideimmunoreactive nerves in the porcine eye. Neurosci Lett 1991; 122:151-3.
14. Lange W, Lang R, Basting C, Ungar JW. Localization of atrial natriuretic peptide/cariodilatin (ANP/CDD)-immunoreactivity in the lacrimal gland of the domestic pig. Exp Eye Res 1990; 50:313-6.
15. Fernandez-Durango R, Trivino A, Ramirez JM, Garcia de la Cob M, Ramirez A, Salazar JJ, Fernanez-Cruz A, Gutkowaska J. Immunoreactive atrial natriuretic factor in aqueous humor: its concentration is increased with high intraocular pressure in rabbit eye. Vision Res 1990; 30:1305-10.
16. Bianchi C, Anand-Scrivastava MB, De Léan A, Gutkowska J, Forthomme D, Genest J. Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eye. Curr Eye Res 1986; 5:283-91.
17. Kutty RK, Fletcher RT, Chader GJ, Krishna G. Expression of guanylate cyclase-A mRNA in the rat retina: detection using polymerase chain reaction. Biochem Biophys Res Commun 1992; 182:851-7.
18. Pang IH, Fleenor DL, Matsumoto S, Steely HT, Desantis L. Presence of functional Type B Natriuretic Peptide Receptor in Human Ocular Cells. Invest Ophthalmol Vis Sci 1996; 37:1724-31.
19. Sugrue MF, Viader M-P. Synthetic atrial natriuretic factor lowers rabbit intraocular pressure. Eur J Pharmacol 1986; 130:349-50.
20. Mittag TW, Tormay A, Ortega M, Severin C. Atrial natriuretic peptide (ANP) guanylate cyclase, and intraocular pressure in the rabbit eye. Curr Eye Res 1987; 6:1189-96.
21. Benezra D, Griffin BW, Maftzir G, Sharif NA, Clark AF. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci 1997; 38:1954-62.
22. Walkenbach RJ, Ye GS, Korenfeld MS, Boney F. Atrial natriuretic petide receptors on the corneal endothelium. Invest Ophthalmol Vis Sci 1993; 34:2538-43.
23. Kim SH, Kim SZ, Kim H, Lee KS, Lee SJ, Seul KH, Koh GY, Cho KW, Kim SH. Co-existence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea. Invest Ophthalmol Vis Sci 2000; 41:2671-7.
24. Zhang Y, Islam M, Akhtar RA. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factorstimulated wound repair in rabbit corneal epithelial cells. Curr Eye Res 2001; 21:748-56.
25. Offord EA, Sharif NA, Mace K, Tromvoukis Y. Spillare, Avanti, O, E., Howe, WL., Pfeifer, AMA. Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci 1999; 40:1091-101.
26. Sharif NA, Wiernas TK, Howe WE, Griffin BW, Offord EA, Pfeifer AMA. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. Invest Ophthalmol Vis Sci 1998; 39:2562-71.
27. Wiernas TK, Griffin BW, Sharif NA. The expression of functionally coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists. Br J Pharmacol 1997; 121:649-56.
28. Sharif NA, Wiernas TK, Griffin BW, Davis TL. Pharmacology of [3H]-pyrilamine binding and the histamine-induced phosphoinositide turnover, Ca2+-mobilization and cytokine release from human corneal epithelial cells. Br J Pharmacol 1998; 125:1336-44.
29. Roberts PJ, Foster GA, Sharif NA, Collins JF. Phosphonate analogs of acidic amino acids: inhibition of excitatory amino acid binding to cerebellar membranes and of the stimulation of cerebellar cyclic GMP levels. Brain Res 1982; 238:475-9.
30. Crider JY, Williams GW, Drace CD, Katoli P, Senchyna M, Sharif NA. Pharmacological characterization of a serotonin receptor (5HT7) stimulating cAMP production in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2003; 44:4837-44.
31. Papazisis KT, Geromichalos GD, Dimitriadis KA, Kortsaris AH. Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods 1997; 208:151-8.
32. Dimitrijevich SD, Reese TJ, Gracy RW, Oakford LX, Howe WE. A transmission electron microscopic study of methods for harvesting epithelial cells from human corneal tissue. Proc. 49th An. Meeting of Electron Microscopy Soc. Amer 1991; 174.
33. Dimitrijevich SD, Reese TJ, Yorio T, Gracy RW. In vitro models of human ocular tissue: Part I. corneal epithelium equivalent. Invest Ophthalmol Vis Sci 1995; 36:S701.
34. Dimitrijevich SD, Gracy RW. Non-Contracting Tissue Equivalents (Skin, Cornea and Conjunctiva), US Pat. 6,471,958, October, 2002.
35. Dimitrijevich SD, Reese TJ, Yorio T, Gracy RW. An in vitro model of the human cornea. Invest Ophthalmol Vis Sci 1995; 36:S701.
36. Ward SL, Walker TL, Dimitrijevich SD. Evaluation of chemically-induced toxicity using an in vitro model of human corneal epithelium. Toxicol In Vitro 1997; 11:121-39.
37. Gamache DA, Dimitrijevich SD, Weimer LK, Lang LS, Spellman JM, Graff G, Yanni JM. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm 1997; 5:117-28.
38. Matic M, Petrov IN, Chen S, Wang C, Dimitrijevich SD, Wolosin JM. Stem cells of the corneal epithelium lack connexins and metabolite transfer capacity. Differentiation 1997; 61:251-60.
39. Shankardas J. Senchyna M and Dimitrijevich, SD. Presence and distribution of 14-3-3 proteins in the human ocular surface. Mol Vis 2008; 14:2604-15.
40. Lu L, Reinach PS, Kao WW. Corneal epithelial wound healing. Exp Biol Med (Maywood) 2001; 226:653-4.
41. Proud D, Sweet J, Stein P, Settipane RA, Kagey-Sobotka A, Freidlaender MH, Lichenstein LM. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990; 85:896-905.
42. Allansmith MR, Ross RN. Ocular Allergy. Clin Allergy 1988; 18:1-13.
43. Sharif NA, Xu S, Hellberg PE, Pang I-H, Gamache DA, Yanni JM. Human conjunctival epithelial cell responses to plateletactivating factor (PAF): signal transduction and release of proinflammatory cytokines. Mol Vis 2009; 15:1153-61.
44. Matsuda Y, Moroshita Y. HS-142-1: a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Cardiovasc Drug Rev 1993; 11:45-59.
45. Imura R, Sano T, Goto J, Yamada K, Matsuda Y. Inhibition by HS-142-1, novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptideinduced relaxation of isolated rabbit aorta through blockade of guanylyl cyclase-linked receptors. Mol Pharmacol 1992; 42:982-90.
46. Matsuda Y. Design and utilization of natriuretic peptide antagonists. In: Samson, WK, Levin, ER, editors. Contemporary endocrinology: natriuretic peptides in health and disease. Chapter 17. Totowa, NJ: Humana Press, Inc; 1997. p 289-307.
47. Glover V, Medvedev A, Sandler M. Isatin is a potent endogenous antagonist of guanylate cyclase-coupled atrial natriuretic peptide receptors. Life Sci 1995; 57:2073-9.
48. Medvedev AE, Clow A, Sandler M, Glover V. Isatin: a link between natriuretic peptides and monoamines? Biochem Pharmacol 1996; 52:385-91.
49. Medvedev AE, Sandler M, Glover V. Interaction of isatin with type-A natriuretic peptide receptor: possible mechanism. Life Sci 1998; 62:2391-8.
50. Sabbatini ME. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Regul Pept 2009; 154:5-15.
51. Miyajima M, Arai H, Okuda O, Hishii M, Nakanishi H, Ishii H, Sato K. Effects of C-type natriuretic peptide (CNP) on water channel aquaporin-4 (AQP4) expression in cultured astrocytes. Brain Res Mol Brain Res 2004; 122:109-15.
52. Rae JL. Ion channels in ocular epithelia. Invest Ophthalmol Vis Sci 1993; 34:2608-12.
53. Scotland RS, Cohen M, Foster P, Lovell M, Mathur A, Ahluwalia A, Hobbs AJ. C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of p-selectin expression. Proc Natl Acad Sci USA 2005; 102:14452-7.
54. Rich A, Farrugia G, Rae JL. Carbon monoxide stimulates a potassium-selective current in rabbit corneal epithelial cells. Am J Physiol 1994; 267:C435-42.
55. Zhong L, Chu E, Chu J, Chu T-C. CNP-induced changes in pHi, cGMP/cAMP and mRNA expression of natriuretic peptide receptors in human trabecular meshwork cells. J Ocul Pharmacol Ther 2003; 19:425-36.
56. Ellis DZ, Nathanson JA, Rabe J, Sweadner KJ. Carbachol and nitric oxide inhibition of Na,K-ATPase activity in bovine ciliary processes. Invest Ophthalmol Vis Sci 2001; 42:2625-31.
57. Rich A, Bartling C, Farrugia G, Rae JL. Effects of pH on the potassium current in rabbit corneal epithelial cells. Am J Physiol 1997; 272:C744-53.
58. Cammarata PR, Braun B, Dimitrijevich SD, Pack J. Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells. Mol Vis 2010; 16:630-8.